Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(57 sites)
United States
City of Hope Comprehensive Cancer Center, Duarte, California University Of California Care Medical Group - Norris Comprehensive Cancer Center And Hospital, Los Angeles, California Stanford Cancer Institute, Palo Alto, California University of Colorado, Aurora, Colorado Florida Cancer Specialists and Research Institute, Sarasota, Florida